Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
11.8M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
7.15M
-
Shares change
-
+12.8K
-
Total reported value, excl. options
-
$5.55M
-
Value change
-
+$48.5K
-
Number of buys
-
8
-
Number of sells
-
-9
-
Price
-
$0.78
Significant Holders of Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) as of Q1 2023
29 filings reported holding HEPA - Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q1 2023.
Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.15M shares
of 11.8M outstanding shares and own 60.76% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.31M shares), BlackRock Inc. (1.6M shares), GEODE CAPITAL MANAGEMENT, LLC (656K shares), STATE STREET CORP (314K shares), RENAISSANCE TECHNOLOGIES LLC (284K shares), ENVESTNET ASSET MANAGEMENT INC (157K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (155K shares), NORTHERN TRUST CORP (132K shares), Bank of New York Mellon Corp (88.7K shares), and MORGAN STANLEY (88.2K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.